LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing syste… Read more
LivaNova PLC - Asset Resilience Ratio
LivaNova PLC (LIVN) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2022)
This chart shows how LivaNova PLC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down LivaNova PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $42.00K | 0.0% |
| Total Liquid Assets | $42.00K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: LivaNova PLC maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
LivaNova PLC Industry Peers by Asset Resilience Ratio
Compare LivaNova PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for LivaNova PLC (1998–2022)
The table below shows the annual Asset Resilience Ratio data for LivaNova PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.00% | $-34.00K | $2.29 Billion | 0.00pp |
| 2021-12-31 | 0.00% | $-2.00K | $2.20 Billion | -1.30pp |
| 2020-12-31 | 1.30% | $31.09 Million | $2.40 Billion | +1.19pp |
| 2018-12-31 | 0.10% | $2.65 Million | $2.55 Billion | -0.01pp |
| 2017-12-31 | 0.12% | $2.94 Million | $2.50 Billion | +0.12pp |
| 2016-12-31 | 0.00% | $-8.00K | $2.34 Billion | -0.27pp |
| 2015-12-31 | 0.27% | $7.00 Million | $2.56 Billion | -8.23pp |
| 2014-12-31 | 8.51% | $25.03 Million | $294.19 Million | 0.00pp |
| 2013-12-31 | 8.51% | $25.03 Million | $294.19 Million | +2.79pp |
| 2012-12-31 | 5.72% | $15.10 Million | $264.04 Million | -1.36pp |
| 2011-12-31 | 7.08% | $15.00 Million | $211.91 Million | +6.60pp |
| 2009-12-31 | 0.48% | $1.00 Million | $207.47 Million | -0.20pp |
| 2008-12-31 | 0.68% | $1.00 Million | $146.21 Million | -0.27pp |
| 2007-12-31 | 0.95% | $1.00 Million | $105.19 Million | +0.22pp |
| 2006-12-31 | 0.73% | $1.00 Million | $136.23 Million | +0.08pp |
| 2005-12-31 | 0.66% | $1.00 Million | $152.30 Million | -22.41pp |
| 2004-12-31 | 23.06% | $22.80 Million | $98.86 Million | +22.98pp |
| 2000-12-31 | 0.08% | $57.54K | $67.99 Million | -3.80pp |
| 1999-12-31 | 3.89% | $1.56 Million | $40.00 Million | -44.35pp |
| 1998-12-31 | 48.24% | $19.20 Million | $39.80 Million | -- |